MRI features of ISCMs, per-lesion basis, total of 70 lesions in 49 patients
Feature | Prevalence |
---|---|
Location (n = 70) | |
Cervical | 16 (23%) |
Cervicothoracic | 2 (3%) |
Thoracic | 40 (57%) |
Thoracic-conus | 1 (1%) |
Conus | 11 (16%) |
Position (n = 62) | |
Central | 23 (37%) |
Eccentric | 35 (56%) |
Exophytic | 4 (6%) |
Morphology (n = 66) | |
Well-circumscribed | 64 (97%) |
Ill-defined | 2 (3%) |
Cord expansion (n = 70) | |
Present | 44 (63%) |
Absent | 26 (37%) |
Enhancement (n = 64) | |
Present | 63 (98%) |
Absent | 1 (2%) |
Enhancement pattern (n = 63) | |
Homogeneous | 31 (49%) |
Heterogeneous | 31 (49%) |
Peripheral (ring) | 1 (2%) |
Size of enhancing lesion, mm, mean (range) | |
Anterior-posterior (n = 63) | 6.5 (1–16) |
Transverse (n = 53) | 7.3 (2–23) |
Superior-inferior (n = 63) | 19.9 (2–114) |
Longitudinal extent, No. of vertebral segments, mean (range) | |
Length of enhancement (n = 63) | 1.4 (1–8) |
Length of cord T2 signal hyperintensity (n = 69) | 4.5 (1–15) |
Ratio, T2 signal/enhancement (n = 63) | 3.6 (1–14) |
T2 signal intensity (n = 70) | |
Hyperintense | 55 (79%) |
Hypointense | 1 (1%) |
Isointense | 14 (20%) |
T1 signal intensity (n = 63) | |
Hyperintense | 10 (16%) |
Hypointense | 5 (8%) |
Isointense | 48 (76%) |
Cystic change (n = 70) | |
Intratumoral | 2 (3%) |
Peritumoral | 0 (0%) |
Intratumoral hemorrhage (n = 70) | 1 (1%) |